Janet Kaczmarczyk

Janet Kaczmarczyk is a seasoned professional in the field of regulatory affairs, currently serving as the Executive Director of Global Regulatory Affairs CMC at Esperion Therapeutics since March 2017. Previous roles include Director of Regulatory CMC at Ophthotech Corp. and Head of CMC/Regulatory CMC/Clinical Supplies at Kyowa Kirin, Inc.-U.S. Janet has also held positions at A Regulatory Writing Company, Bristol-Myers Squibb as a Global Regulatory Affairs Manager, and DuPont Pharmaceuticals as a Regulatory Affairs Associate. Janet Kaczmarczyk holds a Master of Science in Biology from Villanova University and a Bachelor of Science in Microbiology from Penn State University.